ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,275,000 | +93.9% | 70,700 | +2.0% | 0.02% | +87.5% |
| Q1 2019 | $1,689,000 | +122.2% | 69,300 | +29.8% | 0.01% | +100.0% |
| Q4 2018 | $760,000 | -13.9% | 53,400 | -8.1% | 0.00% | 0.0% |
| Q3 2018 | $883,000 | -18.1% | 58,100 | -9.6% | 0.00% | -20.0% |
| Q2 2018 | $1,078,000 | +213.4% | 64,300 | +204.7% | 0.01% | +150.0% |
| Q1 2018 | $344,000 | +1223.1% | 21,100 | +904.8% | 0.00% | – |
| Q4 2017 | $26,000 | +2500.0% | 2,100 | +2000.0% | 0.00% | – |
| Q3 2017 | $1,000 | -98.5% | 100 | -98.7% | 0.00% | – |
| Q2 2017 | $65,000 | -90.9% | 7,800 | -95.0% | 0.00% | -100.0% |
| Q3 2015 | $716,000 | – | 157,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |